Endocrinol Metab.  2015 Mar;30(1):45-46. 10.3803/EnM.2015.30.1.45.

Metformin-Associated Lactic Acidosis

Affiliations
  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Dong-A Medical Center, Dong-A University College of Medicine, Busan, Korea. taret@daum.net

Abstract

No abstract available.


MeSH Terms

Acidosis, Lactic*

Cited by  1 articles

Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes
Eun Young Lee, Sena Hwang, Yong-ho Lee, Seo Hee Lee, Young Mi Lee, Hua Pyong Kang, Eugene Han, Woonhyoung Lee, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
Yonsei Med J. 2017;58(2):312-318.    doi: 10.3349/ymj.2017.58.2.312.


Reference

1. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998; 352:854–865.
2. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015; 38:140–149.
3. Colwell JA. Is it time to introduce metformin in the U.S.? Diabetes Care. 1993; 16:653–655.
4. Stacpoole PW. Lactic acidosis. Endocrinol Metab Clin North Am. 1993; 22:221–245.
5. Stang M, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care. 1999; 22:925–927.
6. Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA. 2014; 312:2668–2675.
7. Salpeter SR, Greyber E, Pasternak GA, Salpeter Posthumous EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010; 1:CD002967.
8. Wiholm BE, Myrhed M. Metformin-associated lactic acidosis in Sweden 1977-1991. Eur J Clin Pharmacol. 1993; 44:589–591.
9. Kim MJ, Han JY, Shin JY, Kim SI, Lee JM, Hong S, Kim SH, Nam MS, Kim YS. Metformin-associated lactic acidosis: predisposing factors and outcome. Endocrinol Metab. 2015; 30:78–83.
10. Bailey CJ, Turner RC. Metformin. N Engl J Med. 1996; 334:574–579.
11. Kang BI, Kim SJ, Kim JH, Gil HW, Yang JO, Lee EY, Hong SY. Two cases of metformin-induced lactic acidosis successfully treated by hemodialysis. Korean J Med. 2011; 80:473–476.
12. Kajbaf F, Lalau JD. Mortality rate in so-called "metformin-associated lactic acidosis": a review of the data since the 1960s. Pharmacoepidemiol Drug Saf. 2014; 23:1123–1127.
13. Renda F, Mura P, Finco G, Ferrazin F, Pani L, Landoni G. Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. Eur Rev Med Pharmacol Sci. 2013; 17:Suppl 1. 45–49.
Full Text Links
  • ENM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr